Denise Sickert

767 total citations
14 papers, 363 citations indexed

About

Denise Sickert is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Denise Sickert has authored 14 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 6 papers in Molecular Biology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Denise Sickert's work include Monoclonal and Polyclonal Antibodies Research (5 papers), Biosimilars and Bioanalytical Methods (4 papers) and T-cell and B-cell Immunology (3 papers). Denise Sickert is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (5 papers), Biosimilars and Bioanalytical Methods (4 papers) and T-cell and B-cell Immunology (3 papers). Denise Sickert collaborates with scholars based in Switzerland, United States and Germany. Denise Sickert's co-authors include Axel Meye, James S. Rush, U. Schmidt, Pascal Espié, Andrea Kießling, Marc Schmitz, Ulrich Klenk, Susanne Fuessel, Bernd Weigle and Manfred Wirth and has published in prestigious journals such as American Journal of Transplantation, Toxicological Sciences and Journal of Immunological Methods.

In The Last Decade

Denise Sickert

13 papers receiving 353 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Denise Sickert Switzerland	9	163	103	73	69	52	14	363
Dávid Medgyesi Hungary	12	203 1.2×	224 2.2×	47 0.6×	52 0.8×	7 0.1×	18	419
Marcos Iglesias Spain	10	120 0.7×	93 0.9×	14 0.2×	31 0.4×	5 0.1×	31	283
Jordan Hartley Germany	4	308 1.9×	83 0.8×	57 0.8×	84 1.2×	2 0.0×	4	471
Ivana Hálová Czechia	13	367 2.3×	168 1.6×	53 0.7×	28 0.4×	15 0.3×	21	509
Kaisa Holmberg United States	7	562 3.4×	192 1.9×	48 0.7×	199 2.9×	55 1.1×	10	965
Jae-Ung Lee South Korea	8	175 1.1×	111 1.1×	10 0.1×	45 0.7×	4 0.1×	13	345
Andrew Abdulahad United Kingdom	7	161 1.0×	98 1.0×	117 1.6×	109 1.6×	11 0.2×	9	413
Hanqing Lin China	9	145 0.9×	121 1.2×	17 0.2×	140 2.0×	28 0.5×	25	384
Chris van der Loos Netherlands	10	140 0.9×	70 0.7×	10 0.1×	38 0.6×	3 0.1×	13	335
Roshi Afshar United States	6	285 1.7×	141 1.4×	11 0.2×	129 1.9×	5 0.1×	10	548

Countries citing papers authored by Denise Sickert

Since Specialization

Citations

This map shows the geographic impact of Denise Sickert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Denise Sickert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Denise Sickert more than expected).

Fields of papers citing papers by Denise Sickert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Denise Sickert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Denise Sickert. The network helps show where Denise Sickert may publish in the future.

Co-authorship network of co-authors of Denise Sickert

This figure shows the co-authorship network connecting the top 25 collaborators of Denise Sickert. A scholar is included among the top collaborators of Denise Sickert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Denise Sickert. Denise Sickert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Kulic, Luka, Gregory Klein, Carsten Hofmann, et al.. (2025). Latest results from the dose‐expansion part (Part 2) of the Brainshuttle™ AD study of trontinemab in people with Alzheimer’s disease. Alzheimer s & Dementia. 21(S5). e104293–e104293.

Avery, Robert L., Chui Ming Gemmy Cheung, Karl G. Csaky, et al.. (2024). Ocular Pharmacodynamics of Intravitreal Faricimab in Patients With Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema. Translational Vision Science & Technology. 13(11). 13–13. 4 indexed citations

McBlane, Fraser, et al.. (2019). A cell-based immunogenicity assay to detect antibodies against chimeric antigen receptor expressed by tisagenlecleucel. Journal of Immunological Methods. 476. 112692–112692. 11 indexed citations

Espié, Pascal, Yanling He, Phillip J. Koo, et al.. (2019). First-in-human clinical trial to assess pharmacokinetics, pharmacodynamics, safety, and tolerability of iscalimab, an anti-CD40 monoclonal antibody. American Journal of Transplantation. 20(2). 463–473. 68 indexed citations

Espié, Pascal, Peter Ulrich, Denise Sickert, et al.. (2018). Characterization of the in vitro and in vivo properties of CFZ533, a blocking and non-depleting anti-CD40 monoclonal antibody. American Journal of Transplantation. 18(12). 2895–2904. 74 indexed citations

Goodman, Joanne, Simon Cowen, Viswanath Devanarayan, et al.. (2018). Feedback from the European Bioanalysis Forum: Focus Workshop on Current Analysis of Immunogenicity: Best Practices and Regulatory Hurdles. Bioanalysis. 10(4). 197–204. 9 indexed citations

Ulrich, Peter, Thierry Flandre, Pascal Espié, et al.. (2018). Nonclinical Safety Assessment of CFZ533, a Fc-Silent Anti-CD40 Antibody, in Cynomolgus Monkeys. Toxicological Sciences. 166(1). 192–202. 14 indexed citations

Mueller, Karen Thudium, Edward Waldron, Stephan A. Grupp, et al.. (2017). CTL019 Clinical Pharmacology and Biopharmaceutics in Pediatric Patients with Relapsed or Refractory (R/R) Acute Lymphoblastic Leukemia (ALL). Clinical Lymphoma Myeloma & Leukemia. 17. S261–S262. 3 indexed citations

Lloyd, Peter, et al.. (2013). Evaluation of Dried Blood Spots for The Quantification of Therapeutic Monoclonal Antibodies and Detection of Anti-Drug Antibodies. Bioanalysis. 5(5). 613–622. 17 indexed citations

10.

Sickert, Denise, et al.. (2008). Improvement of drug tolerance in immunogenicity testing by acid treatment on Biacore. Journal of Immunological Methods. 334(1-2). 29–36. 43 indexed citations

11.

Sickert, Denise, et al.. (2007). Characterization of macrophage subpopulations and microvessel density in carcinomas of the gastrointestinal tract.. PubMed. 27(3B). 1693–700. 6 indexed citations

12.

Sickert, Denise, et al.. (2005). Characterization of macrophage subpopulations in colon cancer using tissue microarrays. Histopathology. 46(5). 515–521. 33 indexed citations

13.

Füssel, S., Denise Sickert, Axel Meye, U. Schmidt, & Manfred P. Wirth. (2003). Multiple tumour marker analyses (PSA, HK2, PSCA, TRP-P8) in primary prostate cancers using quantitative RT-PCR. European Urology Supplements. 2(1). 59–59. 4 indexed citations

14.

Fuessel, Susanne, Denise Sickert, Axel Meye, et al.. (2003). Multiple tumor marker analyses (PSA, hK2, PSCA, trp-p8) in primary prostate cancers using quantitative RT-PCR. International Journal of Oncology. 23(1). 221–8. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact